NIAID Statement on AstraZeneca Vaccine
National Institutes of Health (NIH) sent this bulletin at 03/23/2021 12:30 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
03/23/2021 12:00 AM EDT
Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial.